FGFR2 and central nervous system cancer: Conversely, in patients diagnosed with glioma, diminished expression of FGFR2 and its IIIb/IIIc splice variants shows a strong inverse correlation with tumor malignancy level, consequently predicting poorer patient survival rates (Ohashi et al., 2014).